• SENSEX 80,599.91
    -585.67 (--0.72%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Astrazeneca Pharma India Ltd Pharmaceuticals - Multinational

  • MNC Associate
  • BSE Code : 39.0
  • ISIN : INE203A01020
8,893.50 -293 (-3.18%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    8,840.00

  • Today’s High

    9,221.00

  • Open

    9,175.00

  • Perv Close

    9,186.00

  • 52W Low

    6,220.00

  • 52W High

    10,691.00

Key Indicators

  • P/E(TTM)

    126.95

  • Mar.Cap (₹Cr.)

    22,233.75

  • Div & Yield %

    0.36

  • Book Value(₹)

    308.14

  • Debt-Equity Ratio

    -3.18

  • AGM Date

    01-Aug-2025

  • EPS

    70.05

  • P/E Ratio

    126.95

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    22,233.75

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    5.00

  • BV (₹)

    308.10

  • Sales( ₹ in Cr.)

    1,716.29

  • NP (in Cr.)

    175.13

  • NP Var(%)

    17.0

  • Div%

    1600.0

  • CPS (₹)

    86.00

  • EPS (₹)

    70.10

  • Traded Value (₹ in Lakhs)

    22,232.88

  • 52 Week High

    10,691.00

  • 52 Week Low

    6,220.00

  • Price BSE

    8893.0

  • Price NSE

    8,894.00

  • Market Capital( in Cr.)

    22,232.88

  • P/C Ratio

    103.30

  • P/E Ratio

    126.90

  • Price Vs.BV

    70.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 1,716.29 1,295.53 1,002.97 805.60 813.56 831.81
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,716.29 1,295.53 1,002.97 805.60 813.56 831.81
Other Income 40.63 51.23 26.10 14.76 12.84 12.99
Stock Adjustments 332.94 33.77 48.86 -14.47 -2.95 39.21
Total Income 2,089.86 1,380.53 1,077.93 805.89 823.45 884.01
EXPENDITURE :            
Raw Materials 1,295.95 628.33 408.84 297.49 292.00 344.44
Power and Fuel Cost 5.30 4.87 5.54 8.10 7.37 7.72
Employee Cost 257.44 241.45 259.10 230.21 219.54 216.70
Other Manufacturing Expenses 18.45 14.38 13.79 8.05 9.11 9.04
Selling and Administration Expenses 204.24 234.33 185.72 145.09 129.72 157.18
Miscellaneous Expenses 110.67 21.49 53.95 16.01 17.40 15.24
Employee Benefit Expenses 257.44 241.45 259.10 230.21 219.54 216.70
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,892.05 1,144.85 926.94 704.95 675.14 750.32
Operating Profit 197.81 235.68 150.99 100.94 148.31 133.69
Interest 1.46 1.20 0.63 0.95 1.09 1.14
Gross Profit 196.35 234.48 150.36 99.99 147.22 132.55
Depreciation 39.99 14.94 16.26 16.95 20.13 18.58
Profit Before Tax 156.36 219.54 134.10 83.04 127.09 113.97
Current Tax 60.54 58.93 38.30 22.63 34.83 31.51
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -19.92 -0.90 -3.49 -1.19 -1.04 10.25
Reported Net Profit 115.74 161.51 99.29 61.60 93.30 72.21
Extraordinary Items -59.39 12.45 -26.96 2.05 1.58 0.18
Adjusted Net Profit 175.13 149.06 126.25 59.55 91.72 72.03
Adjustment below Net Profit -1.17 1.00 -2.61 -1.74 3.43 -5.56
P & L Balance brought forward 578.15 455.64 378.96 324.10 232.37 168.22
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 60.00 40.00 20.00 5.00 5.00 2.50
P & L Balance carried down 632.72 578.15 455.64 378.96 324.10 232.37
Dividend 0.00 0.00 0.00 5.00 5.00 2.50
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,600.00 1,200.00 800.00 500.00 100.00 50.00
Dividend Per Share(Rs) 32.00 24.00 16.00 10.00 2.00 1.00
Earnings Per Share-Unit Curr 46.30 64.60 39.72 24.64 37.32 28.88
Earnings Per Share(Adj)-Unit Curr 46.30 64.60 39.72 24.64 37.32 28.88
Book Value 308.14 284.77 235.48 204.56 182.47 145.78
Book Value(Adj)-Unit Curr 308.14 284.77 235.48 204.56 182.47 145.78

Shareholding Pattern

  • Promoter Group

    75.00%

  • Public Share Holding

    25.00%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 18,750,000 75.00 18,750,000 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 18,750,000 75.00 18,750,000 1
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 0 0.00 0 0
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 375 0.00 250 2
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 757,010 3.03 757,010 104
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 46,005 0.18 46,005 10
Mutual Funds / UTI 1,081,874 4.33 1,081,874 60
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12,025 0.05 12,025 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,897,289 7.59 1,897,164 181
2] Non Institution
Bodies Corporate 330,406 1.32 330,406 263
Clearing Members 120 0.00 120 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 99,314 0.40 98,814 1,344
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,666,112 6.66 1,666,112 7
Individuals holding nominal share capital up to Rs. 1 lakh 2,127,884 8.51 2,005,439 32,573
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,023 0.00 1,023 5
Others 102,182 0.41 102,182 1
Sub Total 4,352,711 17.41 4,229,766 34,196
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 25,000,000 100.00 24,876,930 34,378

Company Background

Astrazeneca Pharma India LtdPharmaceuticals - Multinational

  • Astrazeneca Pharma India Ltd
  • BSE Code : 39.0
  • ISIN : INE203A01020

  • Incorporation Year

    1979

  • Registered Office

    Blk N1 12th Flr Manyata Embass
    Rachenahalli Outer Ring Road, Bangalore,
    Karnataka-560045

  • Telephone

    91-080-67748000

  • FAX

    91-080-67748557

  • Chairman

    Shilpa Divekar Nirula

  • Managing Director

    Praveen Rao Akkinepally

  • Company Secretary

    Manasa R

  • Auditor

    Price Waterhouse & Co Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    Integrated Enterprises (I) Ltd
    No. 30 Ramana Resid.,
    4th Cross Sampige Rd,Malleswaram
    Mumbai - Bangalore - 560003

Astrazeneca Pharma India Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Novartis India 967.25 398.23 356.27 23.23 16.64
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10